ExodusPoint Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,124
Closed -$202K 2845
2021
Q4
$202K Sell
13,124
-17,439
-57% -$229K ﹤0.01% 1824
2021
Q3
$266K Buy
30,563
+9,630
+46% +$87.8K ﹤0.01% 1666
2021
Q2
$214K Buy
+20,933
New +$221K ﹤0.01% 1947
2020
Q3
Sell
-109,193
Closed -$970K 2381
2020
Q2
$970K Buy
+109,193
New +$941K 0.03% 760
2019
Q4
Sell
-12,700
Closed -$77K 2003
2019
Q3
$77K Buy
+12,700
New +$71.4K ﹤0.01% 1255
2019
Q2
Sell
-17,597
Closed -$111K 1414
2019
Q1
$111K Buy
+17,597
New +$123K 0.01% 609

Other funds holding NPTN

ExodusPoint Capital Management's NPTN Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 13,124 shares — an estimated $202K sold.

ExodusPoint Capital Management first reported a position in NPTN in Q1 2019 and held it in 6 quarters. The position peaked at $970K in Q2 2020. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • ExodusPoint Capital Management reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 13,124 NEOPHOTONICS CORP shares in Q1 2022, an estimated $202K.
  • ExodusPoint Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2019 and held it in 6 quarters.
  • ExodusPoint Capital Management's NEOPHOTONICS CORP position peaked at $970K in Q2 2020.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.